Open original FDA record ↗Recall record
- FDA identifier
- Z-0481-2021
- Company in FDA record
- Viewray, Inc.
- FDA record creation date
- Nov 20, 2020
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
There is a potential that components of the receive coil can reach elevated temperatures which has the potential to cause a burn injury to the patient or user.
Source facts
- Action
- On 10/20/2020, the firm, ViewRay, Inc, emailed an "Urgent Device Correction" notification to all affected consignees. In addition to informing consignees about the correction, the firm asked consignees to take the following actions.: 1. For Customer using TPDS software ver. 5.2.5 or earlier with optional 3 Plane imaging: - Do: Maintain a distance of at least 5 cm (~2) between the receive coil and the inner surface of the bore wall when using 3 Plane cin treatment imaging (Figure 3 & 4). - Do Not: Select 3 Plane cin treatment imaging if a distance of at least 5 cm (~2) cannot be maintained between the receive coil and the inner surface of the bore wall during treatment. 2. For Customer Using TPDS software ver. 5.3 or later with optional 8 fps enabled: - Do Not: Use 8 fps cin treatment imaging until further guidance is provided by ViewRay. - Do: Use 4 fps cin treatment imaging when treating a patient. 3. If you have any questions related to this letter, please contact ViewRay Customer Support at support@viewray.com or call +1 855-286-8875.
- Initiated
- 2020-10-20
- Root cause
- Device Design
- Terminated
- 2023-10-13
- Distribution
- Worldwide Distribution: US (nationwide) to states of: CA, NY, FL, IL, MI, MO, OR, WI and OUS countries of: France, Germany, Italy, United Kingdom, Taiwan, Netherlands, Israel, and Denmark.
- Recall number
- Z-0481-2021
- Recall status
- Terminated
- CDRH record ID
- 184270
- FDA record created
- 2020-11-20
- Recall event number
- 86661